Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank93
5Y CAGR+23.7%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
+23.7%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.81M | -63.1% |
| 2024 | $31.98M | +365.8% |
| 2023 | $6.87M | +485.9% |
| 2022 | $-1.78M | -379.7% |
| 2021 | $636000.00 | -84.4% |
| 2020 | $4.08M | -63.0% |
| 2019 | $11.02M | +44.2% |
| 2018 | $7.64M | +944.4% |
| 2017 | $732000.00 | +152.1% |
| 2016 | $-1.41M | - |